LeffJ.Overseas trainees in psychiatry. Br J Psychiatry1980;137:288–9.
2.
JuddLLGoldsteinMJRodnickEHJacksonNLP.Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status. Arch Gen Psychiatry1973;29:207–11.
3.
LoudenJBWarringH.Toxic reactions to lithium and haloperidol (letter). Lancet1976;ii:1088.
4.
TalbotDR. Are tranquiliser combinations more effective than a single tranquiliser?Am J Psychiatry1964;121:597–602.
5.
HanlonTEOtaKYAgallianosDDCombined drug treatment of newly hospitalised acutely ill psychiatric patients. Disorders of the Nervous System1969;30:104–16.
6.
BarrDP.Hazards of modern diagnosis and therapy. The price we pay. JAMA1955;159:452–6.
7.
ThorntonWEPrayBJ.Combination drug therapy in psychopharmacology. J Clin Pharmacol1975;15:511–7.
8.
American Pharmaceutical Association.Evaluation of drug interactions. Washington, 1973.
9.
DugalRCailleGAlbertJM.Apparent pharmacokinetic interaction of diazepam and amitriptyline in psychiatric patients: A pilot study. Current Therapy Research1975;18:679.
10.
Office of Health Economics.Medicines, health and the poor world. London: OHE, 1983:29–31.
11.
PeretzSM.Pharmaceuticals in the third world. Trop Doct1983;13:3–5.
12.
World Health Organization.Mental health care in developing countries: A critical appraisal of research findings. WHO Tech Rep Ser1984;698:57.
